You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 15, Aug 11/25, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Venous Thromboembolism
 •Dentistry/ Oral Medicine
 •Cardiovascular System
 •Surgery
 •Surgical Interventions, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Periodontal Surgery for Patients Receiving Anticoagulant Therapy

Sharon Elad, DMD, MSc; Mordechai Findler, MD, DMD, MSc

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In the study reported by Garcia et al,1 we found 2 points of interest from the oral medicine perspective. First, Garcia et al1 reported that the use of low-molecular-weight heparin (LMWH) as bridging treatment in surgical procedures caused excessive postoperative bleeding.

In a pilot study performed by us during the years 1995 to 2000 (unpublished data) at the Oral Medicine Department, Assuta Hospital, Tel-Aviv, Israel, bleeding tendency was investigated in 500 patients treated with anticoagulants after various dental and oral surgical procedures. Of 43 procedures performed in 30 patients from the periodontal surgery subgroup, in which the surgical procedure involved at least one-third of the gingival soft tissue of the jaw, unusual bleeding complications occurred in only 2 patients, with an international normalized ratio greater than 3.5, and in 2 patients in whom warfarin sodium was substituted by LMWH. In these . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Risk of Thromboembolism With Short-term Interruption of Warfarin Therapy
David A. Garcia, Susan Regan, Lori E. Henault, Ashish Upadhyay, Jaclyn Baker, Mohamed Othman, and Elaine M. Hylek
Arch Intern Med. 2008;168(1):63-69.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.